Who would have thought that a technology for detecting breast cancer used today actually had its’ roots dating back to 480 B.C.? Digital Infrared Thermal Imaging (DITI) is a fairly new technology that represents a practice that was once used by Hippocrates. This technology is based on a technique that Hippocrates would use as he spread mud over his patients and then watched to see which areas dried first. It was in those places on the body that could show a disease.

It wasn’t until 1957 that the first modern application of thermography came into existence when a Canadian doctor discovered that the skin temperature over a breast tumor was higher than that of healthy tissue. By 1982, the Food and Drug Administration approved thermography and classified it as an additional diagnostic tool for the detection of breast cancer. However, DITI was introduced as a diagnostic tool before strict protocols were established for both the technicians who performed the scans and the doctors who interpreted the scans. Shortly after its initial beginnings, DITI fell out of favor as a diagnostic tool in the medical community.

There are now stringent protocols both for testing and interpreting. Perhaps due to these guidelines, thermography (as with all digital technology) has exploded in its technique and capabilities. Thermal cameras detect heat given off by the body and display it as a picture on a computer monitor. These images are unique to the person and they remain stable over time. It is because of these characteristics that thermal imaging is a valuable and effective screening tool to determine changes that could point to trouble down the road. As we all know, early cancer detection is important to survival.

Another advantage is that, unlike mammography, there is no radiation and no compression of the breast; two significant reasons some women refuse mammography. Thermography measures temperature changes in the body. Tumors create their own blood vessels. Where there are more blood vessels, there is more heat. It is in these areas on the body that the camera detects changes in heat or temperature.

Medical doctors who interpret the breast scans are board certified thermologists.

Thermography can be utilized by women of all ages. It is not limited by breast density and is ideal for women who have had cosmetic or reconstructive surgery. Cancer typically has a 15 year life span from onset to death. Ideally, women should begin thermographic screenings by age 25. A woman diagnosed with breast cancer at age 40 possibly had the cancer as early as age 30. Since most women do not have a mammogram until age 40, there is a critical time period from age 25 to 39 that thermography could be extremely beneficial.

Thermography does not replace mammography. However, it is an additional tool that is available to women. By combining both technologies, the detection rate increases to 95-98%, surpassing either technology as a stand-alone therapy.

Thermographic screening is not covered by most insurance companies but is surprisingly affordable for most people. For more information or to find a certified clinic in your area, go to www.proactivehealthonline.com.

About The Author

Brenda Witt is co-owner of Proactive Health Solutions in Southern California. She has worked in the medical field for 9 years and is now an American College of Clinical Thermology (ACCT) certified thermographer in the Orange County area. To contact Brenda, email her at brenda@proactivehealthonline.com.

A Quick Note From The Publisher... If you like the article above, you may be interested in the following article which is also related to Cancer... Who is at increased risk for developing mesothelioma Since the late 1800's Asbestos has been mined and used commercially. The use of Asbestos dramatically increased during World War II and since the early 1940's millions of Americans have been exposed to asbestos dust working within industries where initally the risks were not known. There has been widespread exposure to Asbestos by workers within shipyards, mines and mills, producers of asbestos products, workers in the heating and construction industries, and other tradespeople and an increase risk of deveolping mesothelioma has been the result. . Today, the U.S. Occupational Safety and Health Administration (OSHA) sets limits for acceptable levels of asbestos exposure in the workplace. By contrast, the British Government's Health and Safety executive (HSE) states formally that any threshold for mesothelioma must be at a very low level and it is widely agreed that if any such threshold does exists at all, then it cannot currently be quantified. For practical purposes, therefore, HSE...

Cancer, Breast Cancer Treatment News

First-degree family history of prostate cancer does not affect some treatment outcomes (News-Medical-Net) In a first of its kind study, a first-degree family history of prostate cancer has no impact on the treatment outcomes of prostate cancer patients treated with brachytherapy (also called seed implants), and patients with this type of family history have clinical and pathologic characteristics similar to men with no family history at all, according to a January 1 study in the International ... New medical treatment helps Vernon man battle liver cancer (New Jersey Herald) A revolutionary new cancer treatment, only recently available, has succeeded in saving the life of Vernon resident John Dolan, and promises to save many more. Lowell Mayor C. Jeanne Shores resigns from City Council, focuses her efforts on cancer treatment (The Grand Rapids Press) LOWELL -- Mayor C. Jeanne Shores has resigned from the City Council to focus on her treatment for lung cancer, Lowell officials announced tonight. Press File PhotoFormer Lowell Mayor C. Jeanne Shores Shores, 72, had surgery last July to remove... Family History Of Prostate Cancer Does Not Affect Some Treatment Outcomes (Medical News Today) In a first of its kind study, a first-degree family history of prostate cancer has no impact on the treatment outcomes of prostate cancer patients treated with brachytherapy (also called seed implants), and patients with this type of family history have clinical and pathologic characteristics similar